Oracle stock price comes back to earth: is ORCL a buy now?

Oracle (ORCL) has plunged more than 36% from its year-to-date high to about $198, cutting market cap from roughly $967bn to $530bn amid investor concern over a recent $18bn debt raise that pushes total borrowings above $100bn and broader worries about an AI valuation bubble. Credit-market signals have deteriorated—costs to insure against default rose to about 1.11 percentage points (roughly $111,000 per $10mn) and reported CDS exposure jumped materially year-over-year—while scrutiny has focused on large AI-era contracts such as a cited OpenAI data-center deal reportedly worth $30bn per year despite OpenAI’s own revenue outlook of $12.7–$20bn. Operationally Oracle reported Q1 revenue up 12% to $14.9bn, EPS down 2% to $1.01, and remaining performance obligations surged 359% to $455bn, but market skepticism about counterparty risk and cash-flow durability has pressured the stock. Technically ORCL sits below its 50- and 200-day EMAs and key Fibonacci levels, suggesting near-term downside risk before any potential dip-buying opportunity.

Analysis

Oracle shares have declined more than 36% from this year’s peak to about $198, reducing market capitalization from roughly $967 billion to $530 billion and reversing a runup that peaked near $345. Bloomberg-derived credit metrics show investor concern: cost to insure Oracle debt rose to 1.11 percentage points (roughly $111,000 per $10 million) and reported CDS exposure expanded materially year-over-year, coinciding with an $18 billion debt raise that pushes total borrowings above $100 billion to fund large data-center investments.

The company’s strategic pivot into AI-era infrastructure, including the cited OpenAI-linked Stargate arrangements and a reported $30 billion-per-year data-center contract, is under scrutiny because OpenAI’s own revenue outlook (reported at $12.7–$20 billion) leaves counterparty-execution and cash-flow risk ambiguous. Market sentiment is broadly negative toward AI plays, with related names pulling back and high-profile investors trimming exposure.

Operationally Oracle reported RPO up 359% to $455 billion, revenue up 12% to $14.9 billion and EPS down 2% to $1.01, indicating strong backlog but mixed near-term profitability. Technical indicators show the stock below 50- and 200-day EMAs, beneath the 61.8% Fibonacci level and below Supertrend/Ichimoku signals, implying downside risk toward the 78.6% retracement before a credible momentum recovery.

Key Decisions for Investors

• Avoid initiating fresh long positions until Oracle’s credit spreads and debt metrics stabilize and counterparty cash-flow clarity on large AI/data-center contracts (notably OpenAI-related terms) is provided
• If already long, reduce position size or hedge with downside protection such as put options or CDS given the elevated leverage and bearish technical set-up
• For opportunistic buyers, wait for technical confirmation — sustained move back above the 50-day EMA and/or a test and hold at the 78.6% retracement — before scaling in
• Reassess relative exposure to lower-debt software peers and monitor whether the reported RPO converts to realized revenue and free cash flow before increasing allocation